Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Linkesch

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
Blood|July 15, 1997
Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia--a randomized phase-III studyK Geissler, E Koller, E Hubmann, et al.
Bone Marrow Transplantation|October 19, 2004
Lenograstim after autologous peripheral blood progenitor cell transplantation: results of a double-blind, randomized trialN Schmitz, P Ljungman, C Cordonnier, et al.
Annals of Hematology|February 1, 1996
Long-term leukemia-free survival after allogeneic marrow transplantation in patients with acute myelogenous leukemiaH T Greinix, F Keil, S A Brugger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 2, 2005
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumoursJ-L Pico, G Rosti, A Kramar, et al.
Leukemia Research|October 10, 1998
Interferon-alpha for the treatment of elderly patients with chronic myeloid leukaemiaW Hilbe, U Apfelbeck, M Fridrik, et al.
Vox Sanguinis|January 15, 2010
Transfusion policy in ABO-incompatible allogeneic stem cell transplantationN Worel, S Panzer, H W Reesink, et al.
Leukemia & Lymphoma|March 26, 2002
Dose escalation of ara-c may improve response rates in a subgroup of chronic myeloid leukemia patients with poor response to interferon-alpha and low-dose ara-CW Hilbe, T Kühr, U Apfelbeck, et al.
Bone Marrow Transplantation|July 3, 2014
Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationL Tucunduva, A Ruggeri, G Sanz, et al.
Bone Marrow Transplantation|April 5, 2011
What are a patient's current chances of finding a matched unrelated donor? Twenty years' central search experience in a small countryA Rosenmayr, M Pointner-Prager, A Mitterschiffthaler, et al.
Leukemia Research|January 1, 1997
Interferon-alpha-2C and LD ara-C for the treatment of patients with CML: results of the Austrian multi-center phase II studyJ Thaler, W Hilbe, U Apfelbeck, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Blood|July 15, 1997
Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia--a randomized phase-III studyK Geissler, E Koller, E Hubmann, et al.
Bone Marrow Transplantation|October 19, 2004
Lenograstim after autologous peripheral blood progenitor cell transplantation: results of a double-blind, randomized trialN Schmitz, P Ljungman, C Cordonnier, et al.
Annals of Hematology|February 1, 1996
Long-term leukemia-free survival after allogeneic marrow transplantation in patients with acute myelogenous leukemiaH T Greinix, F Keil, S A Brugger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 2, 2005
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumoursJ-L Pico, G Rosti, A Kramar, et al.
Leukemia Research|October 10, 1998
Interferon-alpha for the treatment of elderly patients with chronic myeloid leukaemiaW Hilbe, U Apfelbeck, M Fridrik, et al.
Vox Sanguinis|January 15, 2010
Transfusion policy in ABO-incompatible allogeneic stem cell transplantationN Worel, S Panzer, H W Reesink, et al.
Leukemia & Lymphoma|March 26, 2002
Dose escalation of ara-c may improve response rates in a subgroup of chronic myeloid leukemia patients with poor response to interferon-alpha and low-dose ara-CW Hilbe, T Kühr, U Apfelbeck, et al.
Bone Marrow Transplantation|July 3, 2014
Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationL Tucunduva, A Ruggeri, G Sanz, et al.
Bone Marrow Transplantation|April 5, 2011
What are a patient's current chances of finding a matched unrelated donor? Twenty years' central search experience in a small countryA Rosenmayr, M Pointner-Prager, A Mitterschiffthaler, et al.
Leukemia Research|January 1, 1997
Interferon-alpha-2C and LD ara-C for the treatment of patients with CML: results of the Austrian multi-center phase II studyJ Thaler, W Hilbe, U Apfelbeck, et al.
Pageof 15